Iain Baird is a Board Member of Vibalogics since 2020, Co-Founder, and prior Interim Chief Operating Officer of the company’s Boxborough, Massachusetts business unit. As an industry executive with over 20 years of experience in the pharmaceutical and chemical industries, Iain has held roles such as President, and Vice President of CMC at Avencia Biologics, Vice President of CMC at PharmAthene, and Engineer and Capital Projects Lead for ICI and Zeneca. An engineer by training, Iain has led multiple facility design and construction projects for both stainless steel and single-use production facilities across the pharmaceutical and biologics sector, including build of multi-product facilities supporting the manufacture of gene therapies, oncolytic viruses, and viral vaccines. Iain’s experience further extends to clinical product development and marketed product approval, having contributed to 16 INDs, 3 successful BLAs, and 3 successful NDA across global regulatory arenas. He has further represented clients in preparation for and during global regulatory agency inspections, including remediation efforts for products placed on hold by the FDA. For the past decade, Iain has focused his consulting and advisory business on working with company founders and CEOs, as well as starting his own life science companies. These companies include those developing new biologics, pharmaceuticals, and those in the contract manufacturing services sector. His recent business collaborations include working with OSO BioPharmaceuticals, CANbridge Life Sciences, Gallus Biopharmaceuticals, Brammer Bio, Mikart, Arranta Bio, Vibalogics, and Genezen. Iain holds a Bachelor of Engineering in Mechanical and Electrical Engineering from Robert Gordons University in The United Kingdom.